Rand Capital Announces Second Quarter 2025 Financial Results Conference Call and Webcast
Second Quarter 2025 Conference Call
1:30 p.m. Eastern Time
Phone: (201) 689-8263
Webcast: ir.randcapital.com
A telephonic replay will be available from 5:30 p.m. ET on the day of the call through Monday, August 18, 2025. To listen to the archived call, dial (412) 317-6671 and enter replay PIN 13754384. The webcast replay will be available in the investors' section at ir.randcapital.com, where a transcript will also be posted once available.
ABOUT RAND CAPITAL
Rand Capital Corporation (Nasdaq: RAND) is an externally managed business development company (BDC). The Company's investment objective is to maximize total return to its shareholders with current income and capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. Rand primarily invests in businesses that have sustainable, differentiated and market-proven products, revenue of more than $10 million and EBITDA in excess of $1.5 million. The Company's investment activities are managed by its external investment adviser, Rand Capital Management, LLC. Additional information can be found at the Company's website where it regularly posts information: randcapital.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
5 minutes ago
- Business Wire
RXST LEGAL UPDATE: RxSight, Inc. Sued for Fraud Amid Declining LAL Utilization -- Investors with Losses are Notified to Contact BFA Law before September 22 Class Action Deadline
NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Company's senior executives for potential violations of the federal securities laws. Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Company's senior executives for potential violations of the federal securities laws. Share If you invested in RxSight, you are encouraged to obtain additional information by visiting: Investors have until September 22, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased RxSight securities. The case is pending in the U.S. District Court for the Central District of California and is captioned Makaveev v. RxSight, Inc., et al., No. 25-cv- 01596. Why Was RxSight Sued for Securities Fraud? RxSight is engaged in the manufacture and sale of light adjustable intraocular lenses used in cataract surgery along with capital equipment used with the lenses. The Company's main product is its Light Adjustable Lens (LAL) that can be customized after cataract surgery through a series of non-invasive light treatments. These treatments, using a Light Delivery Device (LDD), adjust the lens's shape and power to optimize vision based on the patient's individual needs and preferences. During the relevant period, the Company touted its strong LAL and LDD sales and failed to disclose 'adoption challenges' in its products. In reality, RxSight was experiencing a slowdown in LAL utilization that was first noted in 2024. The Stock Declines as the Truth Is Revealed On April 3, 2025, before the market opened, RxSight cut its 2025 full-year revenue forecast citing a 'softening' of the market that purportedly occurred 'in the second half of 2024.' On this news, the price of RxSight stock declined roughly 38%, from $26.12 per share on April 2, 2025, to $16.21 per share on April 3, 2025. Then on July 8, 2025, the Company further cut its 2025 full-year revenue forecast. RxSight attributed the adjustment to 'the slower ramp in LAL utilization that was first noted in 2024' and '[a]doption challenges over the last few quarters.' On this news, the price of RxSight stock declined roughly 38%, from $12.79 per share on July 8, 2025, to $7.95 per share on July 9, 2025. Click here for more information: . What Can You Do? If you invested in RxSight you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Why Bleichmar Fonti & Auld LLP? BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named 'Elite Trial Lawyers' by the National Law Journal, among the top '500 Leading Plaintiff Financial Lawyers' by Lawdragon, 'Titans of the Plaintiffs' Bar' by Law360 and 'SuperLawyers' by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Yahoo
33 minutes ago
- Yahoo
After Falling on Earnings, Should You Buy the Dip in ASML Stock?
Key Points ASML has struggled over the past year due to export restrictions on China and order delays. The stock tumbled again after management said it wasn't sure revenue would grow in 2026. Despite those troubles, the stock should still pay off for patient investors in the long run. 10 stocks we like better than ASML › On the surface, ASML Holding's (NASDAQ: ASML) competitive advantages are clear. It's the world's only maker of extreme ultraviolet lithography (EUV) machines, which companies like Taiwan Semiconductor Manufacturing rely on to make the world's most advanced chips. Typically, being the only producer of a high-tech machine is an advantageous position for a company, and it is for ASML, but it hasn't been enough to make the stock a winner recently. While the rest of the artificial intelligence (AI) and semiconductor sectors have been soaring, ASML is down sharply from its peak last year. After delivering an underwhelming earnings report on Wednesday, the stock fell again, losing 8.3%, and it's now off 32% from that record last year. Because its business involves selling very expensive machines, which can cost around $200 million, ASML's results can be volatile quarter to quarter. In the second quarter, the company reported revenue growth of 23% to 7.69 billion euros. This beat estimates at 7.52 billion euros, though that was down less than 1% in the quarter. The company sold 67 new lithography machines, down from 73 in the first quarter. Net bookings were better than expected, increasing from 3.9 billion euros in Q1 to 5.5 billion, a positive growth signal. 2.3 billion euros' worth of those orders were for EUV machines. Further down the income statement, profit was also down slightly on a sequential basis. Gross margin fell from 54% to 53.7%, and earnings per share declined from 6.00 euros in Q1 to 5.90. What's ailing ASML While the second-quarter results were in line with estimates, there were some challenges that are outside of the company's control, but continue to plague the business. First, restrictions on exporting semiconductor technology to China have posed a problem for ASML. Management said on the earnings call that it was lowering its backlog by 1.4 billion euros to 33 billion euros due to order cancellations related to those restrictions. That reduction was related to deep ultraviolet (DUV) lithography machines, which are less advanced than the EUV machines it's best known for. What seemed to be more disappointing to investors were its cautious comments about 2026. CEO Roger Dassen said: "Looking at 2026, we see that our AI customers' fundamentals remain strong. At the same time, we continue to see increasing uncertainty driven by macroeconomic and geopolitical developments. Therefore, while we still prepare for growth in 2026, we cannot confirm it at this stage." Essentially, management is unsure that revenue will grow next year. For the third quarter, the company said it expects 15% revenue growth, to 7.4 billion euros to 7.9 billion euros. What it means for ASML ASML isn't the first tech stock to get dumped by investors for a lack of clarity with its guidance. A number of companies have chosen not to offer guidance due to uncertainty around tariffs, export controls, and volatility in the broader global economy. Arm Holdings did not offer full-year guidance for its new fiscal year in its earnings report in May, and the stock fell as a result. However, that decision wasn't a reflection of weakness, but of uncertainty in both the macroeconomy and with its customer base, which also had not given guidance. However, the strength in AI-related demand is a positive sign for ASML, and investors shouldn't lose sight of long-term tailwinds from AI. For now, ASML is struggling with the vicissitudes of the semiconductor equipment cycle, which operates on a different course than the broader chip sector, but equipment upgrades will come eventually. After Wednesday's sell-off, the stock now trades at a price-to-earnings ratio of about 30, which seems like a fair price to pay for an industry leader with a monopoly in new technology and the potential for accelerating growth from AI. The company continues to expect 44 billion to 60 billion euros in revenue by 2030, and gross margin improving to 56% to 60%. That implies double-digit revenue growth and expanding margins. If the company can deliver on that, the stock should be a winner over the next five years. Do the experts think ASML is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did ASML make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,048% vs. just 180% for the S&P — that is beating the market by 867.59%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 Jeremy Bowman has positions in ASML, Arm Holdings, and Taiwan Semiconductor Manufacturing. The Motley Fool has positions in and recommends ASML and Taiwan Semiconductor Manufacturing. The Motley Fool has a disclosure policy. After Falling on Earnings, Should You Buy the Dip in ASML Stock? was originally published by The Motley Fool
Yahoo
33 minutes ago
- Yahoo
Amazon's AI-Powered AWS, Efficiency Gains, And Consumer Demand Fuel Bullish Q2 Outlook
(NASDAQ:AMZN) is poised to potentially outperform market expectations in its July 31 second-quarter earnings report, driven by a combination of robust U.S. retail sales, advantageous foreign exchange rates, and accelerating demand for its artificial intelligence-related services through Amazon Web Services (AWS). Strong consumer spending and ongoing efficiency gains in its e-commerce operations are also contributing to a positive outlook for the tech giant. Reinforcing this positive sentiment, Bank of America Securities analyst Justin Post maintained (NASDAQ:AMZN) with a Buy rating and raised the price forecast from $248 to $265. Post raised its second-quarter estimates for the company, citing stronger-than-expected U.S. retail data, favorable foreign exchange (FX) movements, and rising AI-related demand via Anthropic. The analyst forecasted second-quarter revenue of $164 billion, exceeding Wall Street's consensus of $162 expects Amazon Web Services (AWS) to grow 16.5% year-over-year, slightly below the first-quarter's 16.9% but in line with Street projections of 17%. However, Post noted that robust AI demand and accelerating AWS infrastructure investments will drive growth reacceleration in the second half of the year. The analyst projects $17.8 billion in second-quarter profit, above the consensus estimate of $17.0 billion and the high end of Amazon's own guidance of $17.5 billion. Key drivers include resilient consumer spending, signs of acceleration in e-commerce trends, and FX benefits, especially with the euro up 5% year-over-year (Y/Y) and 8% quarter-over-quarter (Q/Q) against the dollar, potentially delivering a 130bps FX tailwind vs. the Street's modest 30bps estimate, he noted. In North America Retail, aggregated BAC credit/debit card data and Bloomberg Second Measure point to a 4-point acceleration in sales growth versus the first quarter, Post noted. The analyst said this sets the stage for Amazon to beat Street expectations by over 2% in the region. International Retail could benefit from FX trends, as the Street models only offer a modest boost. Amazon's guidance for the third quarter is expected to range between $169 billion and $174 billion (vs. Street at $172.8 billion) with GAAP EBIT projected between $14.0 billion and $18.0 billion (Street at $19.4 billion), Post noted. He suggested Amazon's historical conservatism could result in cautious guidance, but if second-quarter results show substantial upside, the third-quarter outlook could surprise higher. Post also highlighted reports of AWS job cuts, which may support margin expansion in the second half. The analyst estimates second-quarter AWS operating margins at 36.0%, slightly above the consensus of 35.3%, though down 3.5 points from the first quarter due to higher stock-based compensation. He further noted that AWS capex spending is scaling rapidly, up 38 points Y/Y, now accounting for 70% of Amazon's capex, signaling a ramp in infrastructure buildout that should alleviate previous supply constraints and support future growth. Post said positives that could boost investor confidence included solid second-quarter retail performance from resilient consumer demand, potential third-quarter boost from a longer Prime Day, retail margin leverage from hiring freezes and cost discipline, AWS revenue acceleration tied to increasing AI and chip demand and improved operating efficiency and tax savings from the Big Beautiful Bill, which could add $6.4 billion in incremental cash tax benefits between 2025–2027. Despite trading at 13.4 times 2026 EV/EBITDA, Amazon remains below its 10-year average of 16.5 times, the analyst said, suggesting potential for multiple expansion if growth momentum holds. Upcoming results from Alphabet (NASDAQ:GOOGL) and Microsoft (NASDAQ:MSFT) may also influence sentiment ahead of Amazon's report, Post noted. Post projected second-quarter revenue of $163.92 billion and EPS of $1.40. Price Action: AMZN stock is trading higher by 0.26% to $228.05 at last check Wednesday. Photo via Shutterstock Latest Ratings for AMZN Date Firm Action From To Mar 2022 Deutsche Bank Initiates Coverage On Buy Feb 2022 Tigress Financial Maintains Buy Feb 2022 Credit Suisse Maintains Outperform View More Analyst Ratings for AMZN View the Latest Analyst Ratings Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? (AMZN): Free Stock Analysis Report This article Amazon's AI-Powered AWS, Efficiency Gains, And Consumer Demand Fuel Bullish Q2 Outlook originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
